Tran C - Search Results

1

Monitoring antiproliferative responses to kinase inhibitor therapy in mice with 3'-deoxy-3'-18F-fluorothymidine PET.

Waldherr C, Mellinghoff IK, Tran C, Halpern BS, Rozengurt N, Safaei A, Weber WA, Stout D, Satyamurthy N, Barrio J, Phelps ME, Silverman DH, Sawyers CL, Czernin J. Waldherr C, et al. Among authors: tran c. J Nucl Med. 2005 Jan;46(1):114-20. J Nucl Med. 2005. PMID: 15632041 Free article.

2

Growth inhibitory effects of the dual ErbB1/ErbB2 tyrosine kinase inhibitor PKI-166 on human prostate cancer xenografts.

Mellinghoff IK, Tran C, Sawyers CL. Mellinghoff IK, et al. Among authors: tran c. Cancer Res. 2002 Sep 15;62(18):5254-9. Cancer Res. 2002. PMID: 12234993

3

Hypoxia-inducible factor determines sensitivity to inhibitors of mTOR in kidney cancer.

Thomas GV, Tran C, Mellinghoff IK, Welsbie DS, Chan E, Fueger B, Czernin J, Sawyers CL. Thomas GV, et al. Among authors: tran c. Nat Med. 2006 Jan;12(1):122-7. doi: 10.1038/nm1337. Epub 2005 Dec 11. Nat Med. 2006. PMID: 16341243

4

Impact of animal handling on the results of 18F-FDG PET studies in mice.

Fueger BJ, Czernin J, Hildebrandt I, Tran C, Halpern BS, Stout D, Phelps ME, Weber WA. Fueger BJ, et al. Among authors: tran c. J Nucl Med. 2006 Jun;47(6):999-1006. J Nucl Med. 2006. PMID: 16741310 Free article.

5

MicroPET imaging of prostate cancer in LNCAP-SR39TK-GFP mouse xenografts.

Yang H, Berger F, Tran C, Gambhir SS, Sawyers CL. Yang H, et al. Among authors: tran c. Prostate. 2003 Apr 1;55(1):39-47. doi: 10.1002/pros.10208. Prostate. 2003. PMID: 12640659

6

Overriding imatinib resistance with a novel ABL kinase inhibitor.

Shah NP, Tran C, Lee FY, Chen P, Norris D, Sawyers CL. Shah NP, et al. Among authors: tran c. Science. 2004 Jul 16;305(5682):399-401. doi: 10.1126/science.1099480. Science. 2004. PMID: 15256671

7

HER2/neu kinase-dependent modulation of androgen receptor function through effects on DNA binding and stability.

Mellinghoff IK, Vivanco I, Kwon A, Tran C, Wongvipat J, Sawyers CL. Mellinghoff IK, et al. Among authors: tran c. Cancer Cell. 2004 Nov;6(5):517-27. doi: 10.1016/j.ccr.2004.09.031. Cancer Cell. 2004. PMID: 15542435 Free article.

8

18F-fluorodeoxy-glucose positron emission tomography marks MYC-overexpressing human basal-like breast cancers.

Palaskas N, Larson SM, Schultz N, Komisopoulou E, Wong J, Rohle D, Campos C, Yannuzzi N, Osborne JR, Linkov I, Kastenhuber ER, Taschereau R, Plaisier SB, Tran C, Heguy A, Wu H, Sander C, Phelps ME, Brennan C, Port E, Huse JT, Graeber TG, Mellinghoff IK. Palaskas N, et al. Among authors: tran c. Cancer Res. 2011 Aug 1;71(15):5164-74. doi: 10.1158/0008-5472.CAN-10-4633. Epub 2011 Jun 6. Cancer Res. 2011. PMID: 21646475 Free PMC article.

9

Molecular determinants of resistance to antiandrogen therapy.

Chen CD, Welsbie DS, Tran C, Baek SH, Chen R, Vessella R, Rosenfeld MG, Sawyers CL. Chen CD, et al. Among authors: tran c. Nat Med. 2004 Jan;10(1):33-9. doi: 10.1038/nm972. Epub 2003 Dec 21. Nat Med. 2004. PMID: 14702632

10

AKT activity determines sensitivity to mammalian target of rapamycin (mTOR) inhibitors by regulating cyclin D1 and c-myc expression.

Gera JF, Mellinghoff IK, Shi Y, Rettig MB, Tran C, Hsu JH, Sawyers CL, Lichtenstein AK. Gera JF, et al. Among authors: tran c. J Biol Chem. 2004 Jan 23;279(4):2737-46. doi: 10.1074/jbc.M309999200. Epub 2003 Oct 23. J Biol Chem. 2004. PMID: 14576155 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,537 results

Search Page

Filters